Bradycardia Completed Phase 3 Trials for Remifentanil (DB00899)

Also known as: Heart Rate Low / Bradycardia, unspecified / Heart rate decreased / Bradycardia NOS / Bradycardia (disorder)

IndicationStatusPhase
DBCOND0000504 (Bradycardia)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03065309Determination of Remifentanil's ED50 for Rapid Sequence Intubation Avoiding Bradycardia and Hypotension in AdultsSupportive Care